Stay updated on Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0. Removed Lung cancer, related topics: MedlinePlus Genetics, and Revision: v3.4.3 from the related topics.
    Difference
    0.2%
    Check dated 2026-03-18T22:51:46.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Lung cancer is added as a related topic and MedlinePlus Genetics link appears; the site revision was updated from v3.4.2 to v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-11T18:38:59.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Removed the related topics links 'Lung Cancer' and 'MedlinePlus Genetics' from the page. These related topics are navigation aids and are not part of the study details.
    Difference
    0.2%
    Check dated 2026-03-04T13:53:14.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Added Lung cancer and related topics: MedlinePlus Genetics to the page, providing disease context and a patient education resource related to the study.
    Difference
    0.2%
    Check dated 2026-02-25T09:27:14.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the page footer. Removed the government funding lapse notice about site operating status.
    Difference
    0.5%
    Check dated 2026-02-11T09:26:29.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    Notice: A site-wide funding notice banner was added with a new revision tag (v3.4.1). The related topics 'Lung cancer' and 'MedlinePlus Genetics' were removed.
    Difference
    0.6%
    Check dated 2026-02-04T05:50:19.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page.